Back to results
US 2022/0064285 A1Published application
Anti-ephrin-b2 blocking antibodies for the treatment of fibrotic diseases
AssigneeThe General Hospital Corporation
InventorDavid Lagares
Life of this patent
Estimating the term…
Abstract
Methods and compositions for treating organ fibrosis using antibodies or antigen-binding fragments thereof that bind to and block the soluble Ephrin B2 ectodomain.
Claims14
A method for treating organ fibrosis in a subject, comprising:
- identifying a subject who has organ fibrosis, and administering a therapeutically effective amount of one or more antibodies or antigen binding fragments thereof that bind to and block soluble ephrin-B2 ectodomain.
Dependencies are inferred from the claim text.